Expect a vaccine for children by September, director of Delhi AIIMS Dr. Randeep Guleria, told AajTak. The leading pulmonologist and crucial member of the government's task force on Covid-19 told AajTak that Covaxin's data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected same month. He also said that If Pfizer-BioNTech's vaccine gets a green signal in India then that could also be an option for children. Watch the video.
